EUCTR2010-020215-36-BE进行中（未招募）1 期
A prospective, controlled, double blind, international study to assess the effects of strontium ranelate vs. placebo on the reduction of periprosthetic bone loss in patients with total hip arthroplastyThe Periprosthetic bone loss” study - The Periprosthetic bone loss” study
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 126
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Caucasian men or postmenopausal women,
- •Age = 50 years,
- •Patients with conventional primary total hip arthroplasty, cementless femoral stem and primary coxarthrosis as indication of total hip arthroplasty.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 38
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 88
排除标准
- •Short femoral stem,
- •Any perioperative complication,
- •Patients with inflammatory arthropathy,
- •Impossibility to perform DXA,
- •Increased risk or history of VTE,
- •Known hypersensitivity or contraindication to the study drug or Calperos D3®.
研究者
相似试验
已完成
不适用
An international study to assess the effects of strontium ranelate in the reduction of bone loss around the metal implant, in patients with hip prosthesisPeriprosthetic bone loss / total hip arthroplastyMusculoskeletal DiseasesPeriprosthetic bone lossISRCTN15928978Institut de Recherches Internationales Servier (France)96
进行中（未招募）
不适用
A prospective, controlled, double blind, international study to assess the effects of strontium ranelate vs. placebo on the reduction of periprosthetic bone loss in patients with total hip arthroplastyThe Periprosthetic bone loss” study - The Periprosthetic bone loss” studyReduction of periprosthetic bone loss in patients with total hip arthoplasty for coxarthrosisMedDRA version: 14.1Level: PTClassification code 10052306Term: Periprosthetic osteolysisSystem Organ Class: 10022117 - Injury, poisoning and procedural complicationsEUCTR2010-020215-36-DEInstitut de Recherches Internationales Servier126
进行中（未招募）
不适用
A prospective, controlled, double blind, international study to assess the effects of strontium ranelate vs. placebo on the reduction of periprosthetic bone loss in patients with total hip arthroplasty. The ''Periprosthetic bone loss'' study - The ''Periprosthetic bone loss'' studyReduction of periprosthetic bone loss in patients with total hip arthoplasty for coxarthrosisMedDRA version: 14.0Level: PTClassification code 10052306Term: Periprosthetic osteolysisSystem Organ Class: 10022117 - Injury, poisoning and procedural complicationsEUCTR2010-020215-36-ITINSTITUT DE RECHERCHES INTERNATIONALES SERVIER126
进行中（未招募）
不适用
A prospective, randomized, double-blind, international multicenter trial to investigate the efficacy and safety of NT 201 in comparison to placebo and to compare two different application schemes of NT 201 in the treatment of lateral periorbital wrinkles - NT crow's feetlateral periorbital wrinkles (Crow's feet)MedDRA version: 6.1Level: PTClassification code 10040867EUCTR2006-005396-17-ITMERZ PHARMACEUTICALS GMBH108
进行中（未招募）
1 期
A prospective, randomized, double-blinded, international multicenter trial to investigate the efficacy and safety of NT 201 in comparison to placebo and to compare two different application schemes of NT 201 in the treatment of lateral periorbital wrinkles - NT crow's feetTreatment of lateral periorbital wrinkles (Crow's feet)MedDRA version: 9.1 Level: LLT Classification code 10052611 Term: Crow's feetEUCTR2006-005396-17-GBMerz Pharmaceuticals GmbH108